Trial site
Kumamoto
- 8running trials
- 10closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Chronic myeloid leukaemia2 trials
- Myelodysplastic syndromes2 trials
- Prostate cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- and 3 more
- Phase
- Phase 25 trials
- Phase 35 trials
- Status
- Completed9 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection
Completed
Completed
Completed
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 17 Nov 2026